Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |